These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6295601)

  • 1. VP-16 plus cyclophosphamide in the treatment of advanced lung cancer.
    Estape J; Milla A; Agusti A; Sanchez-Lloret J; Santabarbara P; Rozman C
    Cancer; 1983 Feb; 51(3):385-9. PubMed ID: 6295601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group.
    Banham S; Dorward A; Hutcheon A; Ahmedzai S; Cunningham D; Burnett A; Soukop M; Lucie N; Kaye S
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):2-6. PubMed ID: 2983433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup report.
    Britell JC; Eagan RT; Lee RE
    Cancer Treat Rep; 1979; 63(11-12):2130-1. PubMed ID: 230899
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP-16 in small-cell carcinoma of the lung.
    Ettinger DS; Lagakos S
    Cancer; 1982 Apr; 49(8):1544-54. PubMed ID: 6279269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study.
    O'Bryan RM; Crowley JJ; Kim PN; Epstein RB; Neilan B; Coltman CA; Stuckey WJ; Pazdur R
    Cancer; 1990 Feb; 65(4):856-60. PubMed ID: 2153435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible enhancement of vincristine neuropathy by VP-16.
    Thant M; Hawley RJ; Smith MT; Cohen MH; Minna JD; Bunn PA; Ihde DC; West W; Matthews MJ
    Cancer; 1982 Mar; 49(5):859-64. PubMed ID: 6277454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
    Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
    Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G
    Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination cyclophosphamide and etoposide in treatment of small cell lung cancer.
    Leung WT; Shiu WC; Pang JC
    Med Oncol Tumor Pharmacother; 1990; 7(1):31-4. PubMed ID: 2160034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
    Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M 1.
    Estape J; Milla A; Agusti A; Lloret JS; Palacin A; Soriano E
    Cancer; 1979 Jan; 43(1):72-7. PubMed ID: 761177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
    Pujol JL; Daurès JP; Rivière A; Quoix E; Westeel V; Quantin X; Breton JL; Lemarié E; Poudenx M; Milleron B; Moro D; Debieuvre D; Le Chevalier T
    J Natl Cancer Inst; 2001 Feb; 93(4):300-8. PubMed ID: 11181777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
    Jackson DV; Zekan PJ; Caldwell RD; Slatkoff ML; Harding RW; Case LD; Hopkins JO; Muss HB; Richards F; White DR
    J Clin Oncol; 1984 Dec; 2(12):1343-51. PubMed ID: 6096517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
    Eagan RT; Creagan ET; Ingle JN; Rubin J; Frytak S; Kvols LK; Fleming TR
    Tumori; 1979 Feb; 65(1):105-9. PubMed ID: 442215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.